Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1,019.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,005,374 shares of the real estate investment trust’s stock after purchasing an additional 2,736,993 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 1.21% of Sabra Healthcare REIT worth $56,922,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Cornerstone Wealth Management LLC increased its position in Sabra Healthcare REIT by 256.6% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares in the last quarter. AlphaQuest LLC increased its position in Sabra Healthcare REIT by 309.2% during the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after buying an additional 109,444 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in Sabra Healthcare REIT by 51.2% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock valued at $10,770,000 after buying an additional 195,600 shares in the last quarter. Allianz Asset Management GmbH increased its position in Sabra Healthcare REIT by 9.9% during the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after buying an additional 81,293 shares in the last quarter. Finally, Tred Avon Family Wealth LLC acquired a new position in Sabra Healthcare REIT during the 3rd quarter valued at about $979,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Up 0.7%

Shares of SBRA stock opened at $20.49 on Thursday. The stock’s 50-day simple moving average is $20.11 and its 200-day simple moving average is $19.18. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29. The firm has a market capitalization of $5.17 billion, a PE ratio of 32.02, a P/E/G ratio of 1.62 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.04 and a fifty-two week high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The firm had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is currently 187.50%.

Analyst Ratings Changes

Several brokerages recently issued reports on SBRA. Truist Financial upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. UBS Group upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, February 19th. Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. Finally, Cantor Fitzgerald upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.